• 1
    Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith Jr SC, Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004; 109: 265571.
  • 2
    Vermylen J, Nemmar A, Nemery B, Hoylaerts MF. Ambient air pollution and acute myocardial infarction. J Thromb Haemost 2005; 3: 195561.
  • 3
    Schwartz J, Dockery DW. Increased mortality in Philadelphia associated with daily air pollution concentrations. Am Rev Respir Dis 1992; 145: 6004.
  • 4
    Katsouyanni K, Touloumi G, Samoli E, Gryparis A, Le Tertre A, Monopolis Y, Rossi G, Zmirou D, Ballester F, Boumghar A, Anderson HR, Wojtyniak B, Paldy A, Braunstein R, Pekkanen J, Schindler C, Schwartz J. Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology 2001; 12: 52131.
  • 5
    Dockery DW, Pope III CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris Jr BG, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993; 329: 17539.
  • 6
    Samet JM, Zeger SL, Dominici F, Curriero F, Coursac I, Dockery DW, Schwartz J, Zanobetti A. The National Morbidity, Mortality, and Air Pollution Study. Part II: morbidity and mortality from air pollution in the United States. Res Rep Health Eff Inst 2000; 94: 570.
  • 7
    Wellenius GA, Schwartz J, Mittleman MA. Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. Stroke 2005; 36: 254953.
  • 8
    D'Ippoliti D, Forastiere F, Ancona C, Agabiti N, Fusco D, Michelozzi P, Perucci CA. Air pollution and myocardial infarction in Rome: a case-crossover analysis. Epidemiology 2003; 14: 52835.
  • 9
    Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ Health Perspect 2001; 109: 4059.
  • 10
    Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys MB, Koenig W. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 2001; 22: 1198204.
  • 11
    Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 2002; 105: 15346.
  • 12
    Donaldson K, Stone V, Seaton A, MacNee W. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 2001; 109: 5237.
  • 13
    Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health effects. Lancet 1995; 345: 1768.
  • 14
    Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20: 23228.
  • 15
    Eilertsen KE, Osterud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 2004; 15: 52138.
  • 16
    Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004; 25: 53642.
  • 17
    Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J, Watt M, Agius R, Stout R. Particulate air pollution and the blood. Thorax 1999; 54: 102732.
  • 18
    Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, Salomaa V. Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol 2004; 15: 31928.
  • 19
    Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med 2000; 57: 81822.
  • 20
    Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 2006; 173: 43241.
  • 21
    Ghio AJ, Hall A, Bassett MA, Cascio WE, Devlin RB. Exposure to concentrated ambient air particles alters hematologic indices in humans. Inhal Toxicol 2003; 15: 146578.
  • 22
    ARPA Lombardia. Rapporto sullo stato dell'ambiente in Lombardia. Milan: Regione Lombardia, 2006.
  • 23
    Schwartz J. Assessing confounding, effect modification, and thresholds in the association between ambient particles and daily deaths. Environ Health Perspect 2000; 108: 5638.
  • 24
    Ozkaynak H, Schatz AD, Thurston GD. Relationships between aerosol extinction coefficients derived from airport visual range observations and alternative measures of airborne particle mass. J Air Pollut Control Assoc 1985; 35: 117685.
  • 25
    Quick AJ. Determination of prothrombin. Am J Med Sci 1935; 190: 50111.
  • 26
    Zucker S, Cathey MH, Sox PJ, Hall EC. Standardization of laboratory tests for controlling anticoagulant therapy. Am J Clin Pathol 1970; 53: 34854.
  • 27
    Taylor Jr FB, Kinasewitz GT. The diagnosis and management of disseminated intravascular coagulation. Curr Hematol Rep 2002; 1: 3440.
  • 28
    Rodgers GM. Hemostatic properties of normal and perturbed vascular cells. FASEB J 1988; 2: 11623.
  • 29
    Freedman DS, Joesoef MR, Barboriak JJ, Stallone DD, Byers T. Correlates of leukocyte counts in men. Ann Epidemiol 1996; 6: 7482.
  • 30
    Gilmour PS, Morrison ER, Vickers MA, Ford I, Ludlam CA, Greaves M, Donaldson K, MacNee W. The procoagulant potential of environmental particles (PM10). Occup Environ Med 2005; 62: 16471.
  • 31
    Machado RB, Fabrini P, Cruz AM, Maia E, Da Cunha Bastos A. Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception 2004; 70: 36570.
  • 32
    Task Force on Oral Contraceptives–WHO Special Programme of Research DaRTiHR, World Health Organization, Geneva, Switzerland. A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations. Br J Obstet Gynaecol 1991; 98: 111728.
  • 33
    Prasad RN, Koh SC, Viegas OA, Ratnam SS. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel. Clin Appl Thromb Hemost 1999; 5: 6070.
  • 34
    Zanobetti A, Schwartz J, Samoli E, Gryparis A, Touloumi G, Peacock J, Anderson RH, Le Tertre A, Bobros J, Celko M, Goren A, Forsberg B, Michelozzi P, Rabczenko D, Hoyos SP, Wichmann HE, Katsouyanni K. The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect 2003; 111: 118893.
  • 35
    Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int J Epidemiol 2006; 35: 134754.
  • 36
    Diez Roux AV, Auchincloss AH, Astor B, Barr RG, Cushman M, Dvonch T, Jacobs Jr DR, Kaufman J, Lin X, Samson P. Recent exposure to particulate matter and C-reactive protein concentration in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2006; 164: 43748.
  • 37
    Sarnat JA, Schwartz J, Catalano PJ, Suh HH. Gaseous pollutants in particulate matter epidemiology: confounders or surrogates? Environ Health Perspect 2001; 109: 105361.
  • 38
    Reed MD, Gigliotti AP, McDonald JD, Seagrave JC, Seilkop SK, Mauderly JL. Health effects of subchronic exposure to environmental levels of diesel exhaust. Inhal Toxicol 2004; 16: 17793.
  • 39
    Gong Jr H, Linn WS, Sioutas C, Terrell SL, Clark KW, Anderson KR, Terrell LL. Controlled exposures of healthy and asthmatic volunteers to concentrated ambient fine particles in Los Angeles. Inhal Toxicol 2003; 15: 30525.
  • 40
    Frampton MW, Utell MJ, Zareba W, Oberdorster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst 2004; 126: 147; discussion 4963.
  • 41
    Elder AC, Gelein R, Azadniv M, Frampton M, Finkelstein J, Oberdorster G. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol 2004; 16: 46171.
  • 42
    Samet JM, Dominici F, Zeger SL, Schwartz J, Dockery DW. The National Morbidity, Mortality, and Air Pollution Study. Part I: methods and methodologic issues. Res Rep Health Eff Inst 2000; 94 Pt 1: 514.
  • 43
    Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J, Dockery D, Cohen A. Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect 2000; 108: 41926.